$128.82
1.43% yesterday
NYSE, Nov 12, 10:11 pm CET
ISIN
US0028241000
Symbol
ABT

Abbott Laboratories Stock price

$128.82
-2.56 1.95% 1M
-3.17 2.40% 6M
+15.71 13.89% YTD
+12.38 10.63% 1Y
+26.81 26.28% 3Y
+16.87 15.07% 5Y
+84.63 191.51% 10Y
+109.43 564.44% 20Y
NYSE, Closing price Wed, Nov 12 2025
+1.82 1.43%

New AI Insights on Abbott Laboratories Insights AI Insights on Abbott Laboratories

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
$224.0b
Enterprise Value
$229.2b
Net debt
$5.2b
Cash
$7.7b
Shares outstanding
1.7b
Valuation (TTM | estimate)
P/E
16.1 | 24.8
P/S
5.1 | 5.0
EV/Sales
5.2 | 5.1
EV/FCF
33.1
P/B
4.4
Dividends
DPS
$2.24
Yield 1Y | 5Y
1.7% | 1.8%
Growth 1Y | 5Y
7.7% | 11.2%
Payout 1Y | 3Y
29.2% | 42.0%
Increased
11 Years
Financials (TTM | estimate)
Revenue
$43.8b | $45.1b
EBITDA
$9.7b | $12.0b
EBIT
$8.0b | $10.5b
Net Income
$14.0b | $9.1b
Free Cash Flow
$6.9b
Growth (TTM | estimate)
Revenue
6.4% | 7.6%
EBITDA
10.0% | 35.6%
EBIT
15.2% | 50.6%
Net Income
142.4% | -32.5%
Free Cash Flow
6.7%
Margin (TTM | estimate)
Gross
56.2%
EBITDA
22.2% | 26.7%
EBIT
18.3%
Net
31.9% | 20.1%
Free Cash Flow
15.8%
Financial Health
Equity Ratio
58.6%
Return on Equity
28.1%
ROCE
11.5%
ROIC
19.5%
Debt/Equity
0.3
More
EPS
$8.0
FCF per Share
$4.0
Short interest
1.2%
Employees
114k
Rev per Employee
$370.0k
Show more

Is Abbott Laboratories a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,031 stocks worldwide.

Abbott Laboratories Stock Analysis

Unlock Scores for Free

Analyst Opinions

36 Analysts have issued a Abbott Laboratories forecast:

24x Buy
67%
12x Hold
33%

Analyst Opinions

36 Analysts have issued a Abbott Laboratories forecast:

Buy
67%
Hold
33%

Financial data from Abbott Laboratories

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
43,843 43,843
6% 6%
100%
- Direct Costs 19,209 19,209
5% 5%
44%
24,634 24,634
7% 7%
56%
- Selling and Administrative Expenses 12,021 12,021
5% 5%
27%
- Research and Development Expense 2,867 2,867
8% 8%
7%
9,746 9,746
10% 10%
22%
- Depreciation and Amortization 1,725 1,725
9% 9%
4%
EBIT (Operating Income) EBIT 8,021 8,021
15% 15%
18%
Net Profit 13,977 13,977
142% 142%
32%

In millions USD.

Don't miss a Thing! We will send you all news about Abbott Laboratories directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Abbott Laboratories Stock News

Neutral
Seeking Alpha
one day ago
Dupont (DD) is a leading specialty chemical company in the process of spinning off its electronics business, which in our view should unlock shareholder value. KKR (KKR) is a leading private equity investment firm with a large portion of earnings coming from recurring revenue sources. Alcon (ALC) revenues fell short of consensus estimates for two consecutive quarters, and management lowered its...
Positive
The Motley Fool
3 days ago
Dividend stocks can help meet the needs of a variety of investors. The two dividend stocks below are among the leaders in their industries.
Positive
Barrons
5 days ago
It's been a great year for stocks, but in the past few days the bull market seems to have lost some of its mojo.
More Abbott Laboratories News

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Head office United States
CEO Robert Ford
Employees 114,000
Founded 1888
Website www.abbott.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today